Vanguard Group »

Ambrx Biopharma shares owned by Vanguard Group

Quarter-by-quarter ownership of Ambrx Biopharma shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Ambrx Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Ambrx Biopharma held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ambrx Biopharma by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $20M 1.4M 14.24

More positions owned by Vanguard Group

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Visa Com Cl A (V)

View all positions for Vanguard Group

Top funds holding Ambrx Biopharma

Federated Investors
Alliancebernstein
Altitude Crest Partners
Virtu Financial

View all funds holding Ambrx Biopharma